Treatment response to cyclophosphamide, rituximab, and bortezomib in chronic immune-mediated sensorimotor neuropathies: a retrospective cohort study

Treatment response to cyclophosphamide, rituximab, and bortezomib in chronic immune-mediated sensorimotor neuropathies: a retrospective cohort study

Background: Up to 20% of patients with chronic immune-mediated sensorimotor neuropathies (CIN) do not respond adequately to first-line therapies. However, studies on further treatment are scarce. Methods: We analyzed retrospectively 200 CIN patients regarding disease characteristics and response to...

Full description

Bibliographic Details
Main Authors: Jeremias Motte, Anna Lena Fisse, Nuray Köse, Thomas Grüter, Hannah Mork, Diamantis Athanasopoulos, Miriam Fels, Susanne Otto, Ines Siglienti, Christiane Schneider-Gold, Kerstin Hellwig, Min-Suk Yoon, Ralf Gold, Kalliopi Pitarokoili
Format: Article
Language:English
Published: SAGE Publishing 2021-03-01
Series:Therapeutic Advances in Neurological Disorders
Online Access:https://doi.org/10.1177/1756286421999631

Internet

https://doi.org/10.1177/1756286421999631

Similar Items